"Designing Growth Strategies is in our DNA"
Region : Global | Published Date: Upcoming | Report ID: FBI100176| Status : Upcoming
Antifreeze Proteins (AFPs) or Ice Structuring Proteins (ISPs) refers to polypeptides, generally produced by certain types of organisms such as fungi, bacteria, insects, and animals. Some of the medical applications of antifreeze proteins include cryosurgery, transplantation procedures, and hypothermia therapeutics. Due to the increase in the occurrence of acute and chronic diseases in the current scenario and the near future, there will be an increased demand for an innovative therapeutic approach to deal with the treatment and management of the diseases, that the antifreeze protein will be suited to provide for. According to the National Cancer Institute, approximately 1,735,350 new diagnosis of cancer will occur in the U. S. and an estimated 609,640 people will die from the disease. Due to the increasing investments towards the research in molecular biology, this market is expected to increase and also due to the diverse application of antifreeze protein market.
The growth in the number of applications of antifreeze proteins and their critical applications in the procedures such as transplantation, cryosurgery and hypothermia therapeutics are one of the main reasons for the growth of the market. Also, the recent investments towards the research & developments of the antifreeze protein are also contributing positively towards the growth of the market.
To get information on various segments, share your queries with us
The factor that is expected to inhibit the growth of the market is the huge costs associated with the research & development of the antifreeze proteins. In some of the regions, that are comprised of the emerging markets, such as high research & development costs may be a hindrance towards the launch of new products.
Some of the major companies that are present in the global antifreeze protein market are KANEKA CORPORATION, AquaBounty Technologies, Inc., SIRONA BIOCHEM, Unilever and Protokinetix Inc. and other players.
· Type I
· Type II
· Type III
· Antifreeze glycoprotein
By End Users
· Pharmaceutical companies
· Food industries
· Cosmetic industries
· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
· Latin America (Brazil, Mexico and Rest of Latin America)
· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
At present, insect accounts for the largest proportion of the market, because a number of antifreeze proteins products are derived or sourced from the insects. In terms of applications, the most utilized applications are medical, where a number of critical medical applications are under the research & development processes. Food also has a significant market share due to the increase in the research & development of processes to prevent the freezing of food.
The global antifreeze protein market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America followed by Europe are the two largest markets for antifreeze protein at present and they are expected to account for a large proportion of the market in the forecast period as well. North America has the highest market share due to the increasing research & development (R&D) initiatives for a number of advanced medical procedures. In Asia Pacific region, Japan is expected to provide the largest market opportunity. This is due to a number of research institutions such as NARO Bio-oriented Technology Research Advancement Institution (BRAIN) conducting a number of research studies on the antifreeze proteins.